Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
CRS, Anemias, sickle cell disease, Biological, Diseases, bioengineering, Lymphoma (any), sickle cell trait, platelets, CAR-Ts, Therapies, red blood cells, Pediatric, Adverse Events, white blood cells, Hemoglobinopathies, B-Cell Lymphoma, Biological Processes, Technology and Procedures, immune cells, Immune Disorders, T-Cell Lymphoma, cytogenetics, Cell Lineage, Study Population, Lymphoid Malignancies, Myeloid Malignancies, Clinically relevant, imaging, Quality Improvement , flow cytometry, immune mechanism, white blood cell disorders, molecular testing, newborn screening, NGS
Type: Oral
Hematology Disease Topics & Pathways:
CRS, Anemias, sickle cell disease, Biological, Diseases, bioengineering, Lymphoma (any), sickle cell trait, platelets, CAR-Ts, Therapies, red blood cells, Pediatric, Adverse Events, white blood cells, Hemoglobinopathies, B-Cell Lymphoma, Biological Processes, Technology and Procedures, immune cells, Immune Disorders, T-Cell Lymphoma, cytogenetics, Cell Lineage, Study Population, Lymphoid Malignancies, Myeloid Malignancies, Clinically relevant, imaging, Quality Improvement , flow cytometry, immune mechanism, white blood cell disorders, molecular testing, newborn screening, NGS
Saturday, December 5, 2020: 12:00 PM-1:30 PM
Moderators:
Aziz Nazha, MD,
and
Manja Meggendorfer, PhD, MLL Munich Leukemia Laboratory
Disclosures:
Nazha: incyte: Speakers Bureau; novartis: Speakers Bureau; abbvie: Consultancy; Daiichi Sankyo: Consultancy.
12:00 PM
12:15 PM
12:30 PM
12:45 PM
1:00 PM
1:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH